NCT06566365

Brief Summary

Fascial plane blocks are traditionally considered regional anesthesia techniques, where a mixture of local anesthetic (LA) is injected into a plane between two fascial layers, with the aim of spreading along this anatomical plane to block the nerves lying within or passing through it . Various pathophysiological processes that alter the structure and characteristics of fasciae can affect the spread of the local anesthetic and the success of the block. Diabetes, hormonal changes, and cannabinoid use are among these factors. This study aims to investigate the effects of hormonal changes during the menstrual cycle on subcostal TAP block.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 22, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

November 15, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

2 months

First QC Date

August 21, 2024

Last Update Submit

November 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • visual analogue scale (VAS)

    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."

    postoperative 1st,2nd, 6.- 12.-24. hour

Secondary Outcomes (1)

  • Quality of Recovery - 15

    postoperative 24. hour

Study Arms (4)

Group LB

EXPERIMENTAL

Patients that undergoing subcostal TAP block identified as being in the luteal phase by inquiring about the date of their last menstrual period.

Other: Subcostal Transversus Abdominis Plane Block

Group FB

EXPERIMENTAL

Patients that undergoing subcostal TAP block identified as being in the follicular phase by inquiring about the date of their last menstrual period.

Other: Subcostal Transversus Abdominis Plane Block

Group L

NO INTERVENTION

Patients identified as being in the luteal phase by inquiring about the date of their last menstrual period.

Group F

NO INTERVENTION

Patients identified as being in the follicular phase by inquiring about the date of their last menstrual period.

Interventions

After ensuring airway safety under general anesthesia, a bilateral Transversus Abdominis Plane Block using 20 cc of 0.25% bupivacaine with a subcostal approach under ultrasound guidance will be administered

Group FBGroup LB

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I-II, female, Laparoscopic cholecyctectomy, Subcostal TAP , 18-65 years old patient

You may not qualify if:

  • ASA III-IV
  • \<18 , \>65 years old patients
  • menstrual disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adıyaman Training and Research Hospital

Adıyaman, 02200, Turkey (Türkiye)

Location

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

August 21, 2024

First Posted

August 22, 2024

Study Start

November 15, 2024

Primary Completion

December 30, 2024

Study Completion

December 31, 2024

Last Updated

November 14, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations